It's an exciting day for the future of drug discovery in cancer. Scorpion team members alongside Co-Founder Liron Bar-Peled and scientists at Mass General Brigham authored a new study published in Cell, which looked to uncover which proteins may be druggable across cancer. These findings further attest to our commitment to developing the next generation of targeted cancer therapies and transforming the lives of patients. Read more about the study here: https://lnkd.in/emW-cUDz
Great proof of concept for future cancer treatment!
Expert Storyteller | Communications Leader | Builder of Teams and Brands
2moKnow your team will crack into this code and look forward to what you find.